Deletion of lynx1 reduces the function of α6* nicotinic receptors

The α6 nicotinic acetylcholine receptor (nAChR) subunit is an attractive drug target for treating nicotine addiction because it is present at limited sites in the brain including the reward pathway. Lynx1 modulates several nAChR subtypes; lynx1-nAChR interaction sites could possibly provide drug tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Rell L., O’Neill, Heidi C., Henley, Beverley M., Wageman, Charles R., Drenan, Ryan M., Marks, Michael J., Miwa, Julie M., Grady, Sharon R., Lester, Henry A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716591/
https://www.ncbi.nlm.nih.gov/pubmed/29206881
http://dx.doi.org/10.1371/journal.pone.0188715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716591/
https://www.ncbi.nlm.nih.gov/pubmed/29206881
http://dx.doi.org/10.1371/journal.pone.0188715

Ejemplares similares